A Study Comparing User Experience of Different Delivery Devices for Glucagon
Status:
Completed
Trial end date:
2019-01-03
Target enrollment:
Participant gender:
Summary
The purpose of the study is to learn more about different devices for delivering glucagon
during simulations of severe hypoglycemic (low blood sugar) emergencies. The study will be
carried out using medical manikins to simulate real life scenarios. No drug will be
administered to humans. Part A will last approximately 17 days for Trained Users and
Participants with Diabetes (PWD). Part B will last approximately nine (9) days for Untrained
Users. Each part will be separated by approximately 7 days.